AVEO PHARMACEUTICALS INC 4/A
4/A · AVEO PHARMACEUTICALS INC · Filed Feb 9, 2012
Insider Transaction Report
Form 4/AAmended
KUCHERLAPATI RAJU S
Director
Transactions
- Other
Common Stock
2010-08-30−14,142→ 35,858 total(indirect: By Trust) - Other
Common Stock
2010-08-30+14,142→ 59,653 total - Purchase
Common Stock
2011-03-15$14.44/sh+15,000$216,548→ 74,653 total
Footnotes (5)
- [F1]The increase of shares of directly held common stock was due to a distribution from the Raju Kucherlapti Grantor Retained Annuity Trust No.1 to the reporting person on 08/30/2010. This transaction was not reported on the reporting person's original Form 4.
- [F2]The decrease of shares of indirectly held common stock was due to a distribution from the Raju Kucherlapti Grantor Retained Annuity Trust No.1 to the reporting person on 08/30/2010. This transaction was not reported on the reporting person's original Form 4.
- [F3]Held by the Raju Kucherlapati Grantor Retained Annuity Trust No.1, of which the reporting person is the trustee and exercises sole voting and investment power over the shares of record. The reporting person disclaims beneficial ownership over all such shares, except to the extent of his pecuniary interest therein.
- [F4]The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.01 to $14.85, inclusive. The reporting person undertakes to provide AVEO Pharmaceuticals, Inc., any security holder of AVEO Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
- [F5]The number of shares was incorrectly reported on the reporting person's original Form 4 filed on 03/16/2011.